Biosensors Receives CE Mark for 2.25-mm BioMatrix DES

March 6, 2009—Biosensors International Group, Ltd. (Singapore) announced that it has received CE Mark approval for a 2.25-mm diameter version of its BioMatrix drug-eluting stent system, expanding the device's currently available range to 2.5- to 4-mm stent diameters. The company estimated that 12% to 15% of all percutaneous coronary interventions involve blood vessels with ≤ 2.5-mm diameters. According to BioSensors, the new size BioMatrix stent will be launched in Europe during the next several months. Originally launched in Europe in April 2008, the BioMatrix coating formulation consists of an abluminal biodegradable polymer and the company's Biolimus A9 drug. BioMatrix is not commercially available in China, Japan, or the United States, the company advised.